Vital Signs with Jacob Effron and Nikhil Krishnan cover image

Vital Signs with Jacob Effron and Nikhil Krishnan

Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&D

Dec 14, 2022
39:19
Creator website
Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner